Home Medicine Progression from impaired glucose tolerance to type 2 diabetes in obese children and adolescents: a 3–6-year cohort study in southern Thailand
Article
Licensed
Unlicensed Requires Authentication

Progression from impaired glucose tolerance to type 2 diabetes in obese children and adolescents: a 3–6-year cohort study in southern Thailand

  • Somchit Jaruratanasirikul EMAIL logo , Sudarat Thammaratchuchai , Maneerat Puwanant , Ladda Mo-suwan and Hutcha Sriplung
Published/Copyright: October 14, 2016

Abstract

Background:

Childhood obesity is associated with abnormal glucose metabolism and type 2 diabetes mellitus (T2DM). This study evaluated the prevalence of abnormal glucose metabolism in asymptomatic obese children and adolescents, and determined the percentage of T2DM development after 3–6 years of follow-up.

Methods:

During 2007–2013, 177 obese children and adolescents who had normal fasting plasma glucose (FPG<100 mg/dL) were given an oral glucose tolerance test (OGTT). The participants were classified into four groups: normal glucose tolerance (NGT), NGT-hyperinsulinemia (NGT-HI), impaired glucose tolerance (IGT), and diabetes mellitus (DM). Blood chemistries, including FPG, glycated hemoglobin, and lipid profiles, and liver function test were performed every 6–12 months or when the patient developed any symptom or sign indicative of diabetes.

Results:

Glucose metabolism alterations were detected in 81.4% of the participants: 63.8% with NGT-HI, 15.3% with IGT, and 2.3% with T2DM. The median levels of homeostasis model assessment-insulin resistance (HOMA-IR) in patients with IGT (8.63) were significantly greater than those in the patients with NGT (4.04) (p<0.01). During the follow-up, 22 patients (14.4%) developed T2DM significantly more from the IGT group (nine of 33 cases, 27.3%) than the NGT-HI group (12 of 108 cases, 11.1%) (p=0.022). The predicting parameters for T2DM conversion were weight status, body mass index (BMI), FBG, fasting insulin, alanine transaminase (ALT) levels, and HOMA-IR.

Conclusions:

Glucose metabolism alteration was commonly found among obese adolescents. Factors associated with T2DM development were greater weight status and the severity of insulin resistance as shown by higher HOMA-IR levels.


Corresponding author: Somchit Jaruratanasirikul, MD, Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand, Phone: +66-074-429618, Fax: +66-074-429618

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Gupta N, Goel K, Misra A. Childhood obesity in developing countries: epidemiology, determinants, and prevention. Endocr Rev 2012;33:48–70.10.1210/er.2010-0028Search in Google Scholar

2. Viner RM, White B, Barrett T, Candy D, Gibson P, et al. Assessment of childhood obesity in secondary care: OSCA consensus statement. Arch Dis Child Educ Pract Ed 2012;97:98–105.10.1136/edpract-2011-301426Search in Google Scholar

3. Chavasit V, Kasemsup V, Tontisirin K. Thailand conquered under-nutrition very successfully but has not slowed obesity. Obes Rev 2013;14(Suppl 2):96–105.10.1111/obr.12091Search in Google Scholar

4. Winichagoon P. Thailand nutrition in transition: situation and challenges of maternal and child nutrition. Asia Pac J Clin Nutr 2013;22:6–15.Search in Google Scholar

5. Han JC, Lawlor DA, Kimm SY. Childhood obesity. Lancet 2010;375:1737–48.10.1016/S0140-6736(10)60171-7Search in Google Scholar

6. Morandi A, Maffeis C. Predictors of metabolic risk in childhood obesity. Horm Res Paediatr 2014;82:3–11.10.1159/000362237Search in Google Scholar PubMed

7. Bartoli E, Fra GP, Carvavale Schianca GP. The oral glucose tolerance test (OGTT) revisited. Eur J Intern Med 2011;22:8–12.10.1016/j.ejim.2010.07.008Search in Google Scholar PubMed

8. Brufani C, Ciampalini P, Grossi A, Fiori R, Fintini D, et al. Glucose tolerance status in 510 children and adolescents attending an obesity clinic in central Italy. Pediatr Diabetes 2010;11:47–54.10.1111/j.1399-5448.2009.00527.xSearch in Google Scholar PubMed

9. Morrison KM, Xu L, Tarnopolsky M, Yusuf Z, Atkinson SA, et al. Screening for dysglycemia in overweight youth presenting for weight management. Diabetes Care 2012;35:711–6.10.2337/dc11-1659Search in Google Scholar PubMed PubMed Central

10. Wabitsch M, Hauner H, Hertrampf M, Muche R, Hay B, et al. Type II diabetes mellitus and impaired glucose regulation in Caucasian children and adolescents with obesity living in Germany. Int J Obes Relat Metab Disord 2004;28:307–13.10.1038/sj.ijo.0802555Search in Google Scholar PubMed

11. Zhu H, Zhang X, Li M-Z, Xie J, Yang X-L. Prevalence of type 2 diabetes and pre-diabetes among overweight or obese children in Tianjin China. Diabet Med 2013;30:1457–65.10.1111/dme.12269Search in Google Scholar PubMed

12. Korwutthikulrangsri M, Mahachoklertwattana P, Chanprasertyothin S, Pongratanakul S, Poomthavorn P. Serum fibroblast growth factor 21 in overweight and obese Thai children and adolescents: its relation to glucose metabolism and its change after glucose loading. Clin Endocrinol 2015;83:820–7.10.1111/cen.12808Search in Google Scholar PubMed

13. Tirabanchasak S, Siripunthana S, Supornsilchai V, Wacharasindhu S, Sahakitrungruang T. Insulin dynamics and biochemical markers for predicting impaired glucose tolerance in obese Thai youth. J Pediatr Endocrinol Metab 2015;28:1039–45.10.1515/jpem-2014-0273Search in Google Scholar PubMed

14. World Health Organization. Growth reference data for 5–19 years 2007 WHO reference. Available at: http://www./who/int/growthref/en/. Accessed: 14 September 2015.Search in Google Scholar

15. Department of Health, Ministry of Public Health. Reference for weight, height and nutritional indices in Thai children aged 1 day to 19 years. Bangkok, Thailand: Department of Health, Ministry of Public Health, 2000.Search in Google Scholar

16. Craig ME, Hattersley A, Donaghue K. ISPAD clinical practice consensus guideline 2006–2007. Definition, epidemiology and classification. Pediatr Diabetes 2006;7:343–51.10.1111/j.1399-5448.2006.00216.xSearch in Google Scholar PubMed

17. Ten S, MacLaren N. Insulin resistance syndrome in children. J Clin Endocrinol Metab 2004;89:2526–39.10.1210/jc.2004-0276Search in Google Scholar PubMed

18. Matsuda M, DeFranco RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462–70.10.2337/diacare.22.9.1462Search in Google Scholar PubMed

19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–9.10.1007/BF00280883Search in Google Scholar PubMed

20. Keskin M, Kurtoglu S, Kendirci M, Atabek E, Yazici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 2005;115:e500–3.10.1542/peds.2004-1921Search in Google Scholar PubMed

21. Albareda M, Rodriguez-Espinosa J, Murugo M, de Leiva A, Corcoy R. Assessment of insulin sensitivity and beta-cell function from measurement in the fasting state and during an oral glucose tolerance test. Diabetologia 2000;43:1507–11.10.1007/s001250051561Search in Google Scholar PubMed

22. Likitmaskul S, Kiattisathavee P, Chaichanwatanakul K, Punnakanta L, Angsusingha K, et al. Increasing prevalence of type 2 diabetes mellitus in Thai children and adolescents associated with increasing prevalence of obesity. J Pediatr Endocrinol Metab 2003;16:71–7.10.1515/JPEM.2003.16.1.71Search in Google Scholar PubMed

23. Panamonta O, Thamsiri N, Panamonta M. Prevalence of type II diabetes and metabolic syndrome among overweight school children in Khon Kaen, Thailand. J Med Assoc Thai 2010;93:56–60.Search in Google Scholar

24. Lee JM, Herman WH, Okumura MJ, Gurney JG, Davis MM. Prevalence and determinants of insulin resistance among U.S. adolescents. Diabetes Care 2006;29:2427–32.10.2337/dc06-0709Search in Google Scholar PubMed

25. Levy-Marchal C, Arslanian S, Cutfield W, Sinaiko A, Druet C, et al. Insulin resistance in children: consensus, perspective, and future directions. J Clin Endocrinol Metab 2010;95:5189–98.10.1210/jc.2010-1047Search in Google Scholar PubMed PubMed Central

26. Cho YH, Craig ME, Donaghue KC. Puberty as an accelerator for diabetes complications. Pediatr Diabetes 2014;15:18–26.10.1111/pedi.12112Search in Google Scholar PubMed

27. Roemmich JN, Clark PA, Lusk M, Friel A, Weltman A, et al. Pubertal alterations in growth and body composition. VI. Pubertal insulin resistance: relation to adiposity, body fat, distribution and hormone release. Int J Obes Relat Metab Disord 2002;26:701–9.10.1038/sj.ijo.0801975Search in Google Scholar PubMed

28. Cree-Green M, Triolo TM, Nadeau KJ. Etiology of insulin resistance in youth with type 2 diabetes. Curr Diab Rep 2013;13:81–8.10.1007/s11892-012-0341-0Search in Google Scholar PubMed PubMed Central

29. Weiss R, Taksali SE, Tamborlane WV, Burgert TS, Savoye M, et al. Predictors of changes in glucose tolerance status in obese youth. Diabetes Care 2005;28:902–5.10.2337/diacare.28.4.902Search in Google Scholar PubMed

30. Kleber M, deSousa G, Papcke S, Wabitsch M, Reinehr T. Impaired glucose tolerance in obese white children and adolescents: three to five year follow-up in untreated patients. Exp Clin Endocrinol Diabetes 2011;119:172–6.10.1055/s-0030-1263150Search in Google Scholar PubMed

31. Kleber M, Lass N, Papcke S, Wabitsch M, Reinehr T. One-year follow-up of untreated obese white children and adolescents with impaired glucose tolerance: high conversion rate to normal glucose tolerance. Diabet Med 2010;27:516–21.10.1111/j.1464-5491.2010.02991.xSearch in Google Scholar PubMed

32. Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab 2008;93: s9–30.10.1210/jc.2008-1595Search in Google Scholar PubMed

33. Maffeis C, Pinelli L, Brambilla P, Banzato C, Valzolgher L, et al. Fasting plasma glucose (FPG) and the risk of impaired glucose tolerance in obese children and adolescents. Obesity 2010;18:1437–42.10.1038/oby.2009.355Search in Google Scholar PubMed

34. Grandone A, Amato A, Luongo C, Santoro N, Perrone L, et al. High-normal fasting glucose levels are associated with increased prevalence of impaired glucose tolerance in obese children. J Endocrinol Invest 2008;31:1098–102.10.1007/BF03345659Search in Google Scholar PubMed

Received: 2016-5-18
Accepted: 2016-9-15
Published Online: 2016-10-14
Published in Print: 2016-11-1

©2016 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Puberty – genes, environment and clinical issues
  4. Puberty
  5. Increased levels of bisphenol A (BPA) in Thai girls with precocious puberty
  6. Efficacy and safety of triptorelin 6-month formulation in patients with central precocious puberty
  7. Monitoring treatment of central precocious puberty using basal luteinizing hormone levels and practical considerations for dosing with a 3-month leuprolide acetate formulation
  8. Original Articles
  9. Association between the triglyceride to high-density lipoprotein cholesterol ratio and insulin resistance in Korean adolescents: a nationwide population-based study
  10. Progression from impaired glucose tolerance to type 2 diabetes in obese children and adolescents: a 3–6-year cohort study in southern Thailand
  11. Investigation of the inflammatory biomarkers of metabolic syndrome in adolescents
  12. A 10-year experience using combined lipid-lowering pharmacotherapy in children and adolescents
  13. Prevalence of medically treated children with ADHD and type 1 diabetes in Germany – Analysis of two representative databases
  14. Association of short stature with life satisfaction and self-rated health in children and adolescents: the CASPIAN-IV study
  15. Case Reports
  16. Central precocious puberty in a boy with 22q13 deletion syndrome and NOTCH-1 gene duplication
  17. Non-androgen secreting adrenocortical carcinoma in preadolescence: a case report and literature review
  18. Efficacy of growth hormone therapy in Kearns-Sayre syndrome: the KIGS experience
  19. A unique case of Shwachman-Diamond syndrome presenting with congenital hypopituitarism
Downloaded on 18.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2016-0195/html
Scroll to top button